Search research articles
Contact Us
Filters
Showing results (181-190 of 791) with videos related to
Page
of 80
Sort By:
Journal of Cancer Research and Clinical Oncology
|
March 10, 2017
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia
Verena S Hoffmann, Joerg Hasford, Michael Deininger, et al.
Blood
|
October 23, 2012
Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
Elias Jabbour, Van Morris, Hagop Kantarjian, et al.
Cancers
|
August 29, 2024
Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, et al.
Cancer
|
February 28, 2007
Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns
Hagop M Kantarjian, Jorge Cortes, Francçois Guilhot, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 25, 2013
Detection of dormant chronic myeloid leukemia clones in the bone marrow of patients in complete molecular remission
Alfonso Quintás-Cardama, Srdana Grgurevic, Uri Rozovski, et al.
Leukemia Research
|
July 16, 2003
Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia
Efrosyni Apostolidou, Jorge Cortes, Apostolia Tsimberidou, et al.
Blood
|
June 26, 2023
Representation of the population in need for pivotal clinical trials in lymphomas
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, et al.
Cancer
|
March 15, 2006
t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy
C Cameron Yin, Jorge Cortes, Bedia Barkoh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 8, 2009
A multinational study of health state preference values associated with chronic myelogenous leukemia
Shelagh M Szabo, Adrian R Levy, Catherine Davis, et al.
Clinical Lymphoma & Myeloma
|
March 27, 2007
Management of patients with newly diagnosed chronic myeloid leukemia: opportunities and challenges
Elias Jabbour, Jorge Cortes, Susan O'Brien, et al.
Page
of 80
Search research articles
Search
Showing results (181-190 of 791) with videos related to
Sort By:
Page
of 80
Journal of Cancer Research and Clinical Oncology
|
March 10, 2017
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia
Verena S Hoffmann, Joerg Hasford, Michael Deininger, et al.
Blood
|
October 23, 2012
Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
Elias Jabbour, Van Morris, Hagop Kantarjian, et al.
Cancers
|
August 29, 2024
Global Trial Representation and Availability of Tyrosine Kinase Inhibitors for Treatment of Chronic Myeloid Leukemia
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, et al.
Cancer
|
February 28, 2007
Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns
Hagop M Kantarjian, Jorge Cortes, Francçois Guilhot, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 25, 2013
Detection of dormant chronic myeloid leukemia clones in the bone marrow of patients in complete molecular remission
Alfonso Quintás-Cardama, Srdana Grgurevic, Uri Rozovski, et al.
Leukemia Research
|
July 16, 2003
Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia
Efrosyni Apostolidou, Jorge Cortes, Apostolia Tsimberidou, et al.
Blood
|
June 26, 2023
Representation of the population in need for pivotal clinical trials in lymphomas
Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, et al.
Cancer
|
March 15, 2006
t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy
C Cameron Yin, Jorge Cortes, Bedia Barkoh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 8, 2009
A multinational study of health state preference values associated with chronic myelogenous leukemia
Shelagh M Szabo, Adrian R Levy, Catherine Davis, et al.
Clinical Lymphoma & Myeloma
|
March 27, 2007
Management of patients with newly diagnosed chronic myeloid leukemia: opportunities and challenges
Elias Jabbour, Jorge Cortes, Susan O'Brien, et al.
Page
of 80